Medicine guide

Omlyclo 75 mg/0.5 ml

As listed in the register: Omlyclo 75 mg/0.5 ml, solution injectable en seringue préremplie

75 mg/0.5 ml ·

  • Prescription only
  • Breathing, airways, allergies and cough
Active substance
Omalizumabum
Made by
IQONE HEALTHCARE SWITZERLAND SA

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Asthme allergique, Urticaire chronique spontanée (UCS)

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byIQONE HEALTHCARE SWITZERLAND SA
Active substanceOmalizumabum
Used inBreathing, airways, allergies and cough
Strength75 mg/0.5 ml
ClassificationR03DX05 · Breathing, airways, allergies and cough
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerOmlyclo 75 mg/0.5 ml, solution injectable en seringue préremplie
Packs1 Fertigspritze(n)
Zulassungsnummer69508
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.